Can Ozempic Cause Pancreatitis?

Inception Point AI
  • 0.0 (0)
  • Medicine
  • Updated Weekly

Dr. Ben Synth examines conflicting evidence on Ozempic and pancreatitis risk, comparing observational studies showing nine-fold increases against randomized trials finding no elevated rates. He explains why the answer depends on which data you trust and your personal risk factors, helping listeners make informed decisions about GLP-1 medications. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Episodes

  1. Apr 7

    Can Ozempic Cause Pancreatitis? - Unpack the risks and the research with Dr. Ben Synth

    Join Dr. Ben Synth as he cuts through the fear surrounding Ozempic and GLP-1 medications, tackling the real science behind pancreatitis, thyroid, and gallbladder risks. Using evidence-based medicine instead of headlines, he examines conflicting studies to help you understand if these medications are right for you. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

    1 min

  2. Apr 7

    Can Ozempic Cause Pancreatitis? - Gallstones, Alcohol & Who Should Avoid GLP-1 Drugs

    Ben Synth explores often-overlooked Ozempic risks beyond pancreatitis and thyroid tumors, including gallstones, alcohol interactions, kidney disease, and smoking. He provides a practical nine-point checklist identifying who should exercise caution before starting semaglutide, emphasizing the critical need for thorough patient-doctor discussions about individual risk factors. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

    25 min

  3. Apr 7

    Ozempic Risks - Thyroid Tumors: What Rat Studies Revealed and What We Still Don't Know

    Ben Synth examines the thyroid tumor warning on Ozempic and GLP-1 medications, explaining why the FDA's black box label stems from rat studies showing C-cell tumors—a finding with uncertain human relevance. He explores the biological differences between rodent and human thyroid glands, who should absolutely avoid these drugs, and how to weigh this precautionary warning against proven metabolic benefits. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

    23 min

  4. Apr 7

    Can Ozempic Cause Pancreatitis? - Parsing the Headlines from the Hard Data

    Ben Synth examines the conflicting evidence around Ozempic and pancreatitis risk—from alarming nine-fold increases in observational studies to neutral or protective signals in controlled trials. He explains why the data disagrees, who faces elevated risk, and what symptoms demand immediate medical attention when starting GLP-1 medications. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

    25 min

Trailer

About

Dr. Ben Synth examines conflicting evidence on Ozempic and pancreatitis risk, comparing observational studies showing nine-fold increases against randomized trials finding no elevated rates. He explains why the answer depends on which data you trust and your personal risk factors, helping listeners make informed decisions about GLP-1 medications. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Information